Comments of the Expert Panel of the Ephedra Education Council on the Safety of Dietary Supplements Containing Ephedrine Alkaloids and on the Adverse Event Reports (AERs) and Health Assessments Released by the Food and Drug Administration (FDA) on April 3, 2000

Casinos Not On Gamstop Non Gamstop Casinos Casinos Not On Gamstop Non Gamstop Casinos Casinos Not On Gamstop

> Comments of the Expert Panel of the Ephedra Education
Council on the Safety of Dietary Supplements Containing
Ephedrine Alkaloids and on the Adverse Event Reports (AERs)
and Health Assessments Released by the Food and
Drug Administration (FDA) on April 3, 2000

Docket No. 00N-1200

Ephedra Trade Recommendation. American Herbal Products Association (January 2000).

"Summary of Incidence of Seizures, Strokes, and Myocardial Infarctions in the Population and Estimations of Risk in the Population from Ephedra Products." Stephen E. Kimmel, M.D

Statement of Steven B. Karch, M.D.

"Safety and Benefits of Ephedrine Alkaloid-Containing Dietary Supplements." Norbert P. Page, D.V.M., M.S.,and Theodore Farber, Ph.D., DABT, Toxichemica, International.

Statement of John W. Olney, M.D.

Statement of Grover M. Hutchins, M.D.

"Review and Analysis of 276 Adverse Event Reports in FDA Docket." Theodore Farber, Ph.D., DABT, and Norbert P. Page, M.S., D.V.M.

Statement of Edgar H. Adams, M.S., Sc.D.

"Ephedra Survey Results: 1995 � 1999" Prepared by Arthur Andersen LLP for The American Herbal Products Association. April 28, 2000. (Downloadable 1.74MB .pdf file)

The information on these pages is not a substitute for medical advice from your medical professional.
This site is a resource for accurate information for the media and other interested parties, and not a site for health advice.

Great finds